News Conference News TCT 2019 FORZA: For Intermediate Lesions, OCT-Guided PCI Costs More, Yields Better Outcomes vs FFR Caitlin E. Cox October 01, 2019
News Conference News TCT 2019 GLOBAL LEADERS Post Hoc: Okay to Drop Aspirin After 1 Month in ACS Patients? Todd Neale September 30, 2019
News Conference News TCT 2019 Ultrathin-Strut Orsiro Stent as Good as BioMatrix: BIODEGRADE Michael O'Riordan September 30, 2019
News Conference News TCT 2019 TAVR Improves Health Status Over Surgery in Low-Risk Patients at 1 Year: PARTNER 3 Yael L. Maxwell September 29, 2019
News Conference News TCT 2019 Long-term PARTNER 2A Results Put Spotlight on Paravalvular Leak in TAVR Todd Neale September 29, 2019
News Conference News TCT 2019 Leave It Be: PCI for Stable CAD Before or With TAVR Does Not Lower Mortality Risk Michael O'Riordan September 29, 2019
News Conference News TCT 2019 EXCEL at 5 Years: PCI for Left Main CAD Still Noninferior to CABG Marcus A. Banks September 28, 2019
News Conference News TCT 2019 LEVANT: Patient-Level Data Show No Increase in 5-Year Death for Paclitaxel DCBs in PAD L.A. McKeown September 28, 2019
News Conference News TCT 2019 New COMPLETE Data Affirm Benefit of Nonculprit PCI in STEMI Regardless of Timing Todd Neale September 28, 2019
News Conference News TCT 2019 COAPT at 3 Years: Crossover Patients See Benefits From MitraClip Shelley Wood September 28, 2019
News Conference News TCT 2019 ‘Spooky’ Signal Still Haunts Paclitaxel DCBs in PAD, but Updated Analysis Reassures L.A. McKeown September 28, 2019
News Conference News TCT 2019 Surgical Volume Matters When It Comes to Repair of Primary MR Todd Neale September 28, 2019
News Conference News TCT 2019 Portico Noninferior to Commercial TAVR Valves in IDE Study Caitlin E. Cox September 27, 2019
News Conference News TCT 2019 SCOPE I: Acurate Neo Comes Up Short for Severe Aortic Stenosis Marcus A. Banks September 27, 2019
News Conference News TCT 2019 Leaflet Thickening and Impaired Motion No Worse With TAVR: PARTNER 3 CT Michael O'Riordan September 27, 2019
News Conference News TCT 2019 Safe to Drop P2Y12 Inhibitor at 3 Months in High-Bleeding-Risk Patients: EVOLVE Short DAPT Caitlin E. Cox September 26, 2019
News Conference News TCT 2019 Onyx ONE: Shorter DAPT Plus ZES Noninferior to Polymer-Free Stent in High-Bleeding-Risk Patients L.A. McKeown September 26, 2019
News Conference News TCT 2019 IDEAL-LM Probes Short DAPT and a Bioabsorbable-Polymer Stent in Left Main Disease Michael O'Riordan September 26, 2019
News Conference News TCT 2019 TWILIGHT: Ticagrelor Monotherapy Lowers Bleeding Without Increasing Ischemic Events Yael L. Maxwell September 26, 2019
News Conference News TCT 2019 Robotics and Augmented Reality Show Promise for Improving Access to Care, Reducing Patient Anxiety L.A. McKeown September 25, 2019